4.2 Article

Heterozygous LMNA mutation-carrying iPSC lines from three cardiac laminopathy patients

Journal

STEM CELL RESEARCH
Volume 59, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.scr.2022.102657

Keywords

-

Funding

  1. National Institutes of Health [F32 HL152483, 75N92020D00019, R01 HL113006, R01 HL130020, R01 HL150693, P01 HL141084]

Ask authors/readers for more resources

In this study, three iPSC lines were generated from PBMCs of DCM patients carrying the same LMNA gene mutation. These iPSC lines exhibited normal morphology, expressed pluripotency markers, and could differentiate into the three germ layers. These patient-specific iPSC lines can be used as valuable tools to model the pathological mechanisms of LMNA-DCM in vitro.
ABSTR A C T LMNA-related dilated cardiomyopathy (LMNA-DCM) is caused by pathogenic variants in the LMNA gene and is characterized by left ventricular chamber enlargement, reduced systolic function, and arrhythmia. Here, we generated three human induced pluripotent stem cell (iPSC) lines from peripheral blood mono-nuclear cells (PBMCs) of three DCM patients carrying the same single heterozygous mutation, c.398 G > A, in LMNA. All lines exhibited normal iPSC morphology, expressed high levels of pluripotency markers, showed normal karyotypes, and could differentiate into the three germ layers. These patient-specific iPSC lines can serve as invaluable tools to model in vitro pathological mechanisms of LMNA-DCM.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available